OncoBriefs - Oncology Research News

April 19, 2026

Screening for Breast Cancer: When Finding More Isn't Always Winning

Screening for Breast Cancer: When Finding More Isn't Always Winning

A fly on the wall in the offices of JAMA this spring would have witnessed something remarkable: a polite but pointed academic cage match over one of the biggest questions in cancer medicine. On one side, three epidemiologists - Frerik Smit, Jay Kaufman, and Arnaud Chiolero - raising an eyebrow at...

April 19, 2026

Six Proteins Walk Into a Lab

Six Proteins Walk Into a Lab

The pathologist was halfway through her third coffee when the mass spectrometer spat out something that made her set the mug down. Buried in the proteomic data from 759 tumor samples, six proteins were practically screaming about which stage III colon cancer patients would relapse - and which ones...

April 19, 2026

The Tumor's Witness Protection Program Has Multiple Safe Houses

The Tumor's Witness Protection Program Has Multiple Safe Houses

Triple-negative breast cancer is the villain nobody roots for. It's aggressive, it's sneaky, and it refuses to carry the molecular handles - estrogen, progesterone, and HER2 receptors - that doctors normally grab onto when selecting treatments. About 30% of TNBC patients who receive neoadjuvant...

April 19, 2026

Two Drugs Walk Into a Leukemia Cell: CPX-351 vs. Venetoclax-HMA in the Battle for AML

Two Drugs Walk Into a Leukemia Cell: CPX-351 vs. Venetoclax-HMA in the Battle for AML

Deep inside the bone marrow, a covert operation has been running for decades. Acute myeloid leukemia - AML for short - is the double agent that slipped past your body's counterintelligence, forging fake IDs for rogue blood cells and smuggling them into circulation. For years, oncologists have been...

April 18, 2026

*Bzzzzzt.*

*Bzzzzzt.*

That's not the sound of a bug zapper on your porch. It's the sound of electric fields scrambling cancer cells in someone's pancreas - and the FDA just gave it a thumbs up.

April 18, 2026

Screening for Breast Cancer

Screening for Breast Cancer

Breast cancer has been playing chess while we've been stuck playing checkers. For decades, this cellular villain has watched us throw the exact same screening playbook at every single woman who walks through the door - annual mammograms, same age cutoffs, rinse and repeat - like a heist movie where...

April 17, 2026

Active Wetting and Mechanics of Collective Cancer Invasion

Active Wetting and Mechanics of Collective Cancer Invasion

If tumors ever handed out report cards, most cancer biologists would still be getting an Incomplete in "How Cells Actually Spread." We've spent decades studying individual cancer cells sneaking off on their own little field trips through the body, only to discover that the real troublemakers are...

April 17, 2026

Location, Location, Location: When Your Pancreas Becomes a Bad Neighborhood

Location, Location, Location: When Your Pancreas Becomes a Bad Neighborhood

In real estate, they say it's all about location - and the same turns out to be true inside your body. Your pancreas, that unassuming little organ tucked behind your stomach, is normally a quiet residential district where hardworking acinar cells pump out digestive enzymes like clockwork. But when...

April 17, 2026

Multiscale Mechanisms Driving Tissue Rupture by Invading Cells

Multiscale Mechanisms Driving Tissue Rupture by Invading Cells

Are you tired of your tissue barriers failing to keep out invasive cancer cells? Do your mesothelial linings crumble under the slightest pressure? Well, have we got the study for you! Except, plot twist - the barrier itself is partly to blame. A team of researchers just showed that when ovarian...

April 17, 2026

The Lockpick That Picks Two Locks: A Molecular Double Agent Against Breast Cancer

The Lockpick That Picks Two Locks: A Molecular Double Agent Against Breast Cancer

Most photosensitizers - those light-activated molecules designed to torch cancer cells - never make it past the front door. They float around the cytoplasm like a security team that can't get into the building they're supposed to protect. P-NO3, the molecule at the center of a new study published...

April 17, 2026

The One-Size-Fits-All Mammogram Is Stuck in Traffic

The One-Size-Fits-All Mammogram Is Stuck in Traffic

Breast cancer screening in America has been stuck at the same red light for decades. Every woman over 40, line up, get your annual mammogram, move along - no detours, no express lanes, no consideration for whether you're driving a moped or a semi-truck. Laura Esserman, Olufunmilayo Olopade, and...

April 17, 2026

When Your Colon's Express Route Hits the Last Stop: Rethinking Cancer Screening for Older Adults

When Your Colon's Express Route Hits the Last Stop: Rethinking Cancer Screening for Older Adults

Riding the subway at rush hour, you accept a basic truth: the system wasn't designed to get you specifically where you need to go - it was built for the masses, and you just happen to fit the route. Colonoscopy screening works the same way. The schedule, the intervals, the recommended stops along...

April 16, 2026

IL15-CIK Cells: When Your Immune System Gets a Startup-Style Upgrade

IL15-CIK Cells: When Your Immune System Gets a Startup-Style Upgrade

Pitch deck, slide one: "We're building a platform that takes underperforming security teams, supercharges them with a proprietary activation protocol, and deploys them directly into hostile environments to neutralize rogue actors - all with minimal collateral damage." Sounds like every Series A...

April 16, 2026

Nationwide Mammographic Screening Among Transgender and Gender Diverse Individuals

Nationwide Mammographic Screening Among Transgender and Gender Diverse Individuals

You probably walked past a mammography clinic today, or at least an ad for one - those pastel-pink reminders plastered on bus stops and pharmacy bags telling you to "schedule your screening." But here's a question almost nobody thinks to ask: who are those reminders actually reaching, and who's...

April 16, 2026

Neoadjuvant and Adjuvant Nivolumab with IRE for Liver Cancer

Neoadjuvant and Adjuvant Nivolumab with IRE for Liver Cancer

The intelligence report landed on the desk marked CLASSIFIED: a rogue cell network had gone dark inside the liver, evading every surveillance system the body had deployed. Standard counterintelligence - burning the site with thermal ablation - kept failing, with over half the targets reappearing...

April 16, 2026

Reprogramming Tumor-Associated Neutrophils to Enhance Radio-Immunotherapy

Reprogramming Tumor-Associated Neutrophils to Enhance Radio-Immunotherapy

Every building has a security team - guards posted at doors, patrolling hallways, checking credentials. Your immune system runs a similar operation, with neutrophils acting as the first responders on site whenever something goes wrong. But here's the architectural nightmare nobody planned for: when...

April 16, 2026

The Delivery Service That Actually Works

The Delivery Service That Actually Works

Remember in Squid Game: The Challenge when contestants had to figure out creative ways to get through impossible barriers? Cancer researchers have been playing their own version of that game for decades - except the barrier is the wall of blood vessels surrounding tumors, and the stakes are, well,...

April 15, 2026

BULLETIN: Tiny Silicon Cages Now Moonlighting as Fake Enzymes That Kill Cancer Cells

BULLETIN: Tiny Silicon Cages Now Moonlighting as Fake Enzymes That Kill Cancer Cells

KARLSRUHE, GERMANY - A team of researchers has reportedly convinced silicon-based nanoparticles to cosplay as enzymes, perform chemistry in water without any metals, and then - in a move nobody asked for but everyone needed - sneak into brain and skin cancer cells to activate a cancer-killing drug....

April 15, 2026

Breast Cancer Mortality: The National Average Is Lying to You

Breast Cancer Mortality: The National Average Is Lying to You

Breast cancer mortality in the United States has a reputation problem. On paper, it looks like a success story - deaths dropped by 26% between 2000 and 2019, sliding from 33.6 to 24.8 per 100,000 women. Headlines love that number. Politicians quote it. And if you're a white woman living in a...